{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:39:41Z","timestamp":1792075181989,"version":"4.4.0"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1S","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.juro.2012.11.017","type":"journal-article","created":{"date-parts":[[2012,12,9]],"date-time":"2012-12-09T05:17:09Z","timestamp":1355030229000},"source":"Crossref","is-referenced-by-count":91,"title":["Metabolic Complications of Androgen Deprivation Therapy for Prostate Cancer"],"prefix":"10.1097","volume":"189","author":[{"given":"Philip J.","family":"Saylor","sequence":"first","affiliation":[{"name":"Department of Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2012.11.017_bib1","series-title":"Stat Fact Sheets: Prostate Cancer","year":"2008"},{"key":"10.1016\/j.juro.2012.11.017_bib2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJM199707313370502","article-title":"Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin","volume":"337","author":"Bolla","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2012.11.017_bib3","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jama.292.7.821","article-title":"6-Month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial","volume":"292","author":"D'Amico","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.juro.2012.11.017_bib4","first-page":"1623","article-title":"Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial","volume":"158","author":"Walsh","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.11.017_bib5","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1464-410X.2006.06416.x","article-title":"The rising prevalence of androgen deprivation among older American men since the advent of prostate-specific antigen testing: a population-based cohort study","volume":"98","author":"Barry","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2012.11.017_bib6","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/cncr.20955","article-title":"Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma","volume":"103","author":"Shahinian","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2012.11.017_bib7","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1470-2045(06)70700-8","article-title":"Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy","volume":"7","author":"Messing","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.juro.2012.11.017_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jama.300.2.173","article-title":"Survival following primary androgen deprivation therapy among men with localized prostate cancer","volume":"300","author":"Lu-Yao","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.juro.2012.11.017_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMp068177","article-title":"Obesity and diabetes in the developing world\u2013a growing challenge","volume":"356","author":"Hossain","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2012.11.017_bib10","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2008-0520","article-title":"Update on obesity","volume":"93","author":"Bessesen","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.juro.2012.11.017_bib11","first-page":"110","article-title":"Testosterone, body composition and aging","volume":"22","author":"Vermeulen","year":"1999","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.juro.2012.11.017_bib12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1210\/jc.85.1.60","article-title":"Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men","volume":"85","author":"Grinspoon","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.juro.2012.11.017_bib13","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1210\/jc.84.8.2647","article-title":"Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age","volume":"84","author":"Snyder","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.juro.2012.11.017_bib14","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/S0022-5347(05)64985-3","article-title":"Changes in bone mineral density, lean body mass and fat content as measured by dual energy x-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy","volume":"167","author":"Berruti","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.11.017_bib15","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/jc.87.2.599","article-title":"Changes in body composition during androgen deprivation therapy for prostate cancer","volume":"87","author":"Smith","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.juro.2012.11.017_bib16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.numecd.2007.10.002","article-title":"Sarcopenic obesity: a new category of obesity in the elderly","volume":"18","author":"Zamboni","year":"2008","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.juro.2012.11.017_bib17","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.urology.2003.10.063","article-title":"Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer","volume":"63","author":"Smith","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.juro.2012.11.017_bib18","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1002\/cncr.23440","article-title":"Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer: differences from the classic metabolic syndrome","volume":"112","author":"Smith","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2012.11.017_bib19","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.urology.2007.08.035","article-title":"Adipocytokines, obesity, and insulin resistance during combined androgen blockade for prostate cancer","volume":"71","author":"Smith","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.juro.2012.11.017_bib20","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1210\/jc.86.9.4261","article-title":"The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer","volume":"86","author":"Smith","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.juro.2012.11.017_bib21","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1210\/jc.2005-2507","article-title":"Insulin sensitivity during combined androgen blockade for prostate cancer","volume":"91","author":"Smith","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.juro.2012.11.017_bib22","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/cncr.21381","article-title":"Changes in bone mineral density and body composition during initial and long-term gonadotropin-releasing hormone agonist treatment for prostate carcinoma","volume":"104","author":"Lee","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2012.11.017_bib23","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1200\/JCO.2003.09.534","article-title":"Resistance exercise in men receiving androgen deprivation therapy for prostate cancer","volume":"21","author":"Segal","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2012.11.017_bib24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1042\/CS20020209","article-title":"Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia","volume":"104","author":"Dockery","year":"2003","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.juro.2012.11.017_bib25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0022-5347(01)67239-2","article-title":"Effects of the luteinizing hormone-releasing hormone agonist leuprolide on lipoproteins, fibrinogen and plasminogen activator inhibitor in patients with benign prostatic hyperplasia","volume":"154","author":"Eri","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.11.017_bib26","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(07)61778-4","article-title":"Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths","volume":"370","author":"Lewington","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.juro.2012.11.017_bib27","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1001\/jama.1986.03380200061022","article-title":"Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded?","volume":"256","author":"Stamler","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/j.juro.2012.11.017_bib28","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.juro.2012.11.017_bib29","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/archinte.164.13.1427","article-title":"Effectiveness of statin therapy in adults with coronary heart disease","volume":"164","author":"Wilt","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.juro.2012.11.017_bib30","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1056\/NEJM199604113341504","article-title":"Hyperinsulinemia as an independent risk factor for ischemic heart disease","volume":"334","author":"Despres","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2012.11.017_bib31","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/01.CIR.98.5.398","article-title":"Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study","volume":"98","author":"Pyorala","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.juro.2012.11.017_bib32","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer","volume":"24","author":"Keating","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2012.11.017_bib33","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.juro.2012.11.017_bib34","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.2337\/dc08-S012","article-title":"Standards of medical care in diabetes\u20132008","volume":"31","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.juro.2012.11.017_bib35","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1210\/jc.2006-0944","article-title":"Metabolic syndrome: a solution in search of a problem","volume":"92","author":"Ferrannini","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.juro.2012.11.017_bib36","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2337\/diacare.28.9.2289","article-title":"The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes","volume":"28","author":"Kahn","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.juro.2012.11.017_bib37","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1200\/JCO.2006.05.9741","article-title":"Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy","volume":"24","author":"Braga-Basaria","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2012.11.017_bib38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2796.2004.01426.x","article-title":"Adiponectin\u2013journey from an adipocyte secretory protein to biomarker of the metabolic syndrome","volume":"257","author":"Trujillo","year":"2005","journal-title":"J Intern Med"},{"key":"10.1016\/j.juro.2012.11.017_bib39","doi-asserted-by":"crossref","first-page":"3A","DOI":"10.1016\/j.amjcard.2005.11.010","article-title":"The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease","volume":"97","author":"Haffner","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.juro.2012.11.017_bib40","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(08)60602-9","article-title":"Can metabolic syndrome usefully predict cardiovascular disease and diabetes?","volume":"371","author":"Sattar","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.juro.2012.11.017_bib41","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1172\/JCI119628","article-title":"Insulin resistance and hypersecretion in obesity","volume":"100","author":"Ferrannini","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.juro.2012.11.017_bib42","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.2337\/diacare.29.s1.06.s43","article-title":"Diagnosis and classification of diabetes mellitus","volume":"29","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.juro.2012.11.017_bib43","unstructured":"Allibhai SMDHM, Sutradar R, Fleshner NE, Warde P, Cheung AM and Paszat L: Impact of androgen deprivation therapy (ADT) on bone, cardiovascular, and endocrine outcomes: a propensity-matched analysis of 20,000 patients. Unpublished data."},{"key":"10.1016\/j.juro.2012.11.017_bib44","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/cncr.22933","article-title":"Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer","volume":"110","author":"Saigal","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2012.11.017_bib45","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.ijrobp.2004.08.047","article-title":"Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma\u2013long-term results of phase III RTOG 85-31","volume":"61","author":"Pilepich","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.juro.2012.11.017_bib46","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.2007.12.3752","article-title":"Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31","volume":"27","author":"Efstathiou","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2012.11.017_bib47","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1200\/JCO.2007.13.9881","article-title":"Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610","volume":"26","author":"Roach","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2012.11.017_bib48","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.eururo.2008.01.021","article-title":"Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02","volume":"54","author":"Efstathiou","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.11.017_bib49","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1200\/JCO.2005.04.7423","article-title":"Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891","volume":"24","author":"Studer","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2012.11.017_bib50","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/jnci\/djm168","article-title":"Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality","volume":"99","author":"Tsai","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2012.11.017_bib51","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1200\/JCO.2006.09.3369","article-title":"Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions","volume":"25","author":"D'Amico","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2012.11.017_bib52","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1200\/JCO.2007.13.9931","article-title":"Regarding the influence of adjuvant suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarction: how real is the risk?","volume":"25","author":"Roach","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2012.11.017_bib53","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/jnci\/85.12.979","article-title":"Noncancer deaths in white adult cancer patients","volume":"85","author":"Brown","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2012.11.017_bib54","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.juro.2012.11.017_bib55","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2012.11.017_bib56","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/0026-0495(90)90190-N","article-title":"Nutritional and metabolic effects of gonadotropin-releasing hormone agonist treatment for prostate cancer","volume":"39","author":"Tayek","year":"1990","journal-title":"Metabolism"},{"key":"10.1016\/j.juro.2012.11.017_bib57","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1200\/JCO.2007.13.5517","article-title":"Toremifene improves lipid profiles in men receiving androgen-deprivation therapy for prostate cancer: interim analysis of a multicenter phase III study","volume":"26","author":"Smith","year":"2008","journal-title":"J Clin Oncol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534712054821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534712054821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2012.11.017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T02:57:57Z","timestamp":1651201077000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2012.11.017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":57,"journal-issue":{"issue":"1S","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["10.1016\/j.juro.2012.11.017"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2012.11.017","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}